{ "ok": true, "cik": "78003", "ticker": "PFE", "name": "PFIZER INC", "filings": [ { "form": "10-Q", "filed": "2026-08-04", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000095/0000078003-26-000095-index.htm" }, { "form": "8-K", "filed": "2026-08-04", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000094/0000078003-26-000094-index.htm" }, { "form": "8-K", "filed": "2026-06-18", "items": [ "7.01 Regulation FD Disclosure" ], "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000087/0000078003-26-000087-index.htm" }, { "form": "8-K", "filed": "2026-06-18", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm" }, { "form": "10-Q", "filed": "2026-05-05", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000054/0000078003-26-000054-index.htm" }, { "form": "8-K", "filed": "2026-05-05", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000053/0000078003-26-000053-index.htm" } ], "events12m": 10, "healthWatch": { "window": "last 12 months", "since": "2025-09-26", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 1, "latest": { "filed": "2026-06-18", "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000078003.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=78003" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up PFIZER INC ($PFE). Last filing: 10-Q, 2026-08-04. 10 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 62579000000, "revenueGrowth1y": -0.01647099501783833, "revenueGrowthPerYear": -0.06329994626819124, "yearsOfData": 5, "operatingMargin": null, "operatingMarginPrior": null, "netMargin": 0.12483420955911728, "operatingCashFlow": 11704000000, "capitalSpending": 2629000000, "freeCashFlow": 9075000000, "researchAndDevelopment": 10437000000, "researchShareOfRevenue": 0.16678118857763788, "cash": 1142000000, "longTermDebt": 64638000000, "longTermDebtChange": 0.057005494505494525, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 81288000000 }, { "fiscalYearEnd": "2022-12-31", "revenue": 101175000000 }, { "fiscalYearEnd": "2023-12-31", "revenue": 59553000000 }, { "fiscalYearEnd": "2024-12-31", "revenue": 63627000000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 62579000000 } ], "totalEquity": 86476000000, "totalAssets": 208160000000, "equityRatio": 0.4154304381245196, "returnOnEquity": 0.09033720338591054, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": 1.72, "dividendYearsRising": 15, "dividendCut": false, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": 1.37, "sharesOutstanding": 5713000000, "bookValuePerShare": 15.13670575879573, "revenuePerShare": 10.9537896026606, "range80": { "low": 39943531534.99886, "high": 75570875389.81247, "baseline": 57433534135.70787, "n": 1471, "band": "b10", "bandLabel": "$10B+", "method": "v4.1", "credibility": 0.5, "growthYears": 4, "ownVolatility": 0.32472080562822236, "classVolatility": 0.06659579566308972, "volatility": 0.23439134114536073 }, "ifPaceHeld": { "low": 39943531534.99886, "high": 75570875389.81247 } }, "edgarette": "🔖 Exposure: revenue $62.6B (FY2025), total debt $64.6B. Experience: revenue down 1.6% on the year, down 6.3% a year over 4 years. Soundness: equity 41.5% of assets, return on equity 9.0%, dividend per share up 15 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $39.9B and $75.6B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; on a year the method never saw, 83.4% landed inside). In a shock year the stress range is $30.2B to $97.6B. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): growth -1.6% against 13.7%.", "peers": { "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2834", "growth": [ 0.1365, 111 ], "opMargin": [ -0.038, 114 ], "equityRatio": [ 0.4028, 118 ], "returnOnEquity": [ -0.0112, 100 ], "payoutRatio": [ 0.403, 13 ] }, "summary": "Pfizer (PFE) saw revenue fall 1.6% in FY2025 to $62.6 billion, equity 41.5% of assets, and dividend per share up 15 years running. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
PFIZER INC against its own record and its peers
Revenue, on the yearPeer median 13.7%-1.6%Equity of assetsPeer median 40.3%41.5%Return on equityPeer median -1.1%9.0%Gold tick: the median of 100–118 peers with $50M+ revenue in pharmaceutical preparations
", "chartHorizon": "
Handed back now, or kept to compound
Of each dollar of profitHanded back per share$1.72up 15 years runningRevenue growth it managed-1.6%last year, for comparison

Gold is paid out to shareholders; navy is kept in the business. Retained profit times return on equity is the pace a company can fund from itself. Facts from the filings, not a recommendation.

", "backtest": { "tests": 11, "hits": 5, "rate": 0.45454545454545453, "method": "v4", "byYear": { "2011": [ 0, 1 ], "2012": [ 1, 1 ], "2013": [ 1, 1 ], "2018": [ 0, 1 ], "2019": [ 0, 1 ], "2020": [ 1, 1 ], "2021": [ 0, 1 ], "2022": [ 0, 1 ], "2023": [ 0, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-26T16:33:39.799Z", "hash": "d588efe7b40e41f0", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Pfizer (PFE) saw revenue fall 1.6% in FY2025 to $62.6 billion, equity 41.5% of assets, and dividend per share up 15 years running. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 62579000000, "totalDebt": 64638000000, "cash": 1142000000 }, "experience": { "revenueGrowth1y": -0.01647099501783833, "revenueGrowthPerYear": -0.06329994626819124, "operatingMargin": null, "operatingMarginPrior": null, "netMargin": 0.12483420955911728, "freeCashFlow": 9075000000 }, "soundness": { "equityRatio": 0.4154304381245196, "returnOnEquity": 0.09033720338591054, "payoutRatio": null, "dividendPerShare": 1.72, "dividendYearsRising": 15, "dividendCut": false, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2834", "growth": [ 0.1365, 111 ], "opMargin": [ -0.038, 114 ], "equityRatio": [ 0.4028, 118 ], "returnOnEquity": [ -0.0112, 100 ], "payoutRatio": [ 0.403, 13 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-09-26", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 1, "latest": { "filed": "2026-06-18", "url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000085/0000078003-26-000085-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 39943531534.99886, "high": 75570875389.81247, "baseline": 57433534135.70787, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 1471, "sizeBand": "$10B+", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341 }, "credibility": { "weightOnOwnRecord": 0.5, "growthYears": 4, "ownVolatility": 0.32472080562822236, "classVolatility": 0.06659579566308972, "pricedVolatility": 0.23439134114536073, "k": 3 }, "stress": { "low": 30185926203.520473, "high": 97569754852.81467, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 11, "hits": 5, "rate": 0.45454545454545453, "method": "v4", "byYear": { "2011": [ 0, 1 ], "2012": [ 1, 1 ], "2013": [ 1, 1 ], "2018": [ 0, 1 ], "2019": [ 0, 1 ], "2020": [ 1, 1 ], "2021": [ 0, 1 ], "2022": [ 0, 1 ], "2023": [ 0, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-26T16:33:39.799Z", "hash": "d588efe7b40e41f0", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000078003.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=78003" }, "speedCash": { "fiscalYear": 2025, "cashConversion": 0.187, "growth3y": -0.148, "volatility": 0.3247, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.4154, "quadrant": { "code": "sj", "label": "Slow and jumpy", "plain": "growing slower than its size class, with revenue that swings more" }, "compass": { "code": "fading", "inside": "Turns 18.7% of revenue into operating cash; revenue shrinking 14.8% a year over three years; no common dividend.", "outside": "Among $10B+ companies: 65th percentile for cash, 1st for growth.", "emoji": "🍂", "label": "Fading", "plain": "slow and jumpy, lagging its peers" }, "band": "$10B+", "cashPctInClass": 65, "growthPctInClass": 1, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "slowjumpy", "text": "slow and jumpy: growing slower than its size class, with revenue that swings more" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±31%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 2, "name": "Weathered boat", "plain": "two warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": 11704000000, "investing": -1351000000, "financing": -10304000000, "capitalSpending": 2629000000, "free": 9075000000, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": 32580000000, "free": 29869000000 }, { "fiscalYearEnd": "2022-12-31", "operating": 29267000000, "free": 26031000000 }, { "fiscalYearEnd": "2023-12-31", "operating": 8700000000, "free": 4793000000 }, { "fiscalYearEnd": "2024-12-31", "operating": 12744000000, "free": 9835000000 }, { "fiscalYearEnd": "2025-12-31", "operating": 11704000000, "free": 9075000000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 1142000000, "shortTerm": 9183000000, "longTerm": 1000000, "equityHoldings": 2596000000, "totalAssets": 208160000000, "ladder": null, "currentRatio": 1.16, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": { "fiscalYear": 2025, "cashConversion": 0.187, "growth3y": -0.148, "volatility": 0.3247, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.4154, "quadrant": { "code": "sj", "label": "Slow and jumpy", "plain": "growing slower than its size class, with revenue that swings more" }, "compass": { "code": "fading", "inside": "Turns 18.7% of revenue into operating cash; revenue shrinking 14.8% a year over three years; no common dividend.", "outside": "Among $10B+ companies: 65th percentile for cash, 1st for growth.", "emoji": "🍂", "label": "Fading", "plain": "slow and jumpy, lagging its peers" }, "band": "$10B+", "cashPctInClass": 65, "growthPctInClass": 1, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "slowjumpy", "text": "slow and jumpy: growing slower than its size class, with revenue that swings more" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±31%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 2, "name": "Weathered boat", "plain": "two warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": 11704000000, "investing": -1351000000, "financing": -10304000000, "capitalSpending": 2629000000, "free": 9075000000, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": 32580000000, "free": 29869000000 }, { "fiscalYearEnd": "2022-12-31", "operating": 29267000000, "free": 26031000000 }, { "fiscalYearEnd": "2023-12-31", "operating": 8700000000, "free": 4793000000 }, { "fiscalYearEnd": "2024-12-31", "operating": 12744000000, "free": 9835000000 }, { "fiscalYearEnd": "2025-12-31", "operating": 11704000000, "free": 9075000000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 1142000000, "shortTerm": 9183000000, "longTerm": 1000000, "equityHoldings": 2596000000, "totalAssets": 208160000000, "ladder": null, "currentRatio": 1.16, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }